-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G0tbq0PLVSC+c0LaCNGcG1xEXgfLVZJSIh5FDPma36sy7jU0SMqvkWv2mS3F5vGQ BduJN5w+XYmMV4boldoq/g== 0001181431-07-076914.txt : 20071220 0001181431-07-076914.hdr.sgml : 20071220 20071220165756 ACCESSION NUMBER: 0001181431-07-076914 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071211 FILED AS OF DATE: 20071220 DATE AS OF CHANGE: 20071220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WORLD HEART CORP CENTRAL INDEX KEY: 0001024520 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7799 PARDEE LANE CITY: OAKLAND STATE: CA ZIP: 94621 BUSINESS PHONE: 510-563-5000 MAIL ADDRESS: STREET 1: 7799 PARDEE LANE CITY: OAKLAND STATE: CA ZIP: 94621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28882 FILM NUMBER: 071319876 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 3 1 rrd183196.xml FORM 4 X0202 3 2007-12-11 0 0001024520 WORLD HEART CORP WHRT 0000815094 ABIOMED INC 22 CHERRY HILL DRIVE DANVERS MA 01923 0 0 1 0 8% Secured Convertible Promissory Note 1.7489 2017-12-11 Common Stock 2858861 D Warrant (right to buy) 0.01 2012-12-11 Common Stock 3400000 D All or any portion of the principal amount of the Note then outstanding shall be convertible at any time and from time to time from after December 11, 2007. $1 million of the Note is outstanding as of December 11, 2007 and an additional $4,000,000 is to be funded on or about January 3, 2007. The principal amount of the Note is convertible at $1.7489, subject to anti-dilution adjustments in the event that World Heart Corporation issues securities at a lower effective price, at any time. The Note will accrue interest at 8% per annum and, at the option of ABIOMED, the interest may be converted into common shares at the then market value. This warrant is immediately exercisable for up to 680,000 shares of common stock and will become exercisable for the remaining 2,720,000 shares of common stock on or about January 3, 2008. /s/ Michael R. Minogue, Chairman, CEO and President for ABIOMED, Inc. 2007-12-20 -----END PRIVACY-ENHANCED MESSAGE-----